Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Progesterone Resistance × LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gynecologic 1

Conditions

Prostatic Neoplasms 2 Progesterone Resistance 1 Polycystic Ovary Syndrome 1 Obesity 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1

Interventions

Letrozole 2 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06379113 2025-08-11

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Fudan University

Phase 2/3 Recruiting

GynecologicOther

Progesterone Resistance, Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡